Glucose Viaflo Baxter (Glucose)

Glucose Viaflo Baxter is used in medical practice to address specific metabolic and fluid needs during patient care.

• Provide an immediate source of glucose for patients unable to intake nutrition orally.
• Support energy metabolism in perioperative and critical‑care settings.
• Assist in the correction of hypoglycemia when rapid carbohydrate replacement is required.
• Contribute to fluid replacement and electrolyte balance as part of a balanced intravenous therapy regimen.
• Serve as a carrier for compatible intravenous medications that require a glucose-containing diluent.
• Facilitate the maintenance of blood osmolarity during infusion therapy.

When administered intravenously, Glucose Viaflo Baxter may be associated with a range of observed effects, most of which are mild, self‑limiting, and transient.

Common

• Mild hyperglycemia that resolves with monitoring.
• Transient increase in serum osmolality.
• Local irritation at the infusion site.
• Temporary nausea or light‑headedness.
• Mild electrolyte shifts, such as a slight decrease in serum potassium.
• Transient increase in blood lactate levels, occasionally observed.

Serious

• Severe hyperglycemia requiring medical intervention.
• Fluid overload leading to pulmonary edema.
• Allergic reaction such as rash, itching, or anaphylaxis.
• Severe electrolyte imbalance, including marked potassium shifts that may affect cardiac rhythm.
• Rapid infusion causing hypotension or cardiac stress.

Healthcare professionals should observe specific precautions when preparing and administering Glucose Viaflo Baxter to ensure patient safety and product integrity.

• Verify patient identity and confirm indication before infusion.
• Use aseptic technique and inspect the solution for particulate matter or discoloration.
• Adjust infusion rate according to individual fluid and glucose requirements.
• Monitor blood glucose levels regularly during and after administration.
• Assess for signs of fluid overload, especially in patients with cardiac or renal impairment.
• Ensure compatibility with other intravenous medications; avoid mixing with solutions that may precipitate.
• Document the product lot number and expiration date in the patient record.

Glucose Viaflo Baxter may interact with other agents administered intravenously; awareness of potential interactions helps guide safe co‑administration.

Avoid

• Co‑infusion with high‑concentration potassium solutions, which can cause rapid shifts in serum potassium.
• Simultaneous administration with hypertonic saline or other high‑osmolarity fluids that may exacerbate fluid overload.
• Mixing with calcium-containing solutions may cause precipitation.

Use with caution

• Concurrent use of insulin therapy; glucose infusion may require insulin dose adjustments.
• Administration alongside diuretics, especially loop diuretics, as fluid balance may be affected.
• Use with caution in patients receiving catecholamines, as glucose can influence hemodynamic responses.